Skip to main content

Table 3 Chromosomal microarray analysis of VSD fetuses with normal karyotyping results

From: Chromosomal abnormalities and copy number variations in fetal ventricular septal defects

Case

CMA results

Size (Mb)

Prenatal ultrasound

Pathogenicity classification

Obstetrical outcomes

Inheritance

1

arr[hg19]22q11.21(18,648,855-21,800,471) × 1

3.1

VSD; RAA; vascular circle; ALSA

P (DiGeorge syndrome)

TP

de novo

2

arr[hg19]22q11.21(18,648,855-21,800,471) × 1

3.1

VSD; ARA; PA; thymic hypoplasia

P (DiGeorge syndrome)

TP

de novo

3

arr[hg19]22q11.21(18,631,364-20,729,389) × 1

2.0

VSD; thymic hypoplasia

P (DiGeorge syndrome)

TP

de novo

4

arr[hg19]22q11.21(18,648,855-21,800,471) × 1

3.1

VSD; RAA

P (DiGeorge syndrome)

TP

de novo

5

arr[hg19]22q11.21(18,648,855-21,800,471) × 1

3.1

VSD; ARSA; TR; LSVC; Single umbilical artery

P (Cat Eye Syndrome)

TP

de novo

6

arr[hg19]22q11.1q11.21(16,888,899-18,649,190) × 4

1.7

VSD; ARSA; TR; LSVC; Single umbilical artery

P (Cat Eye Syndrome)

TP

de novo

7

arr[hg19]17p11.2(16,567,623-18,743,354) × 3

2.1

VSD; PA; FGR

P (Potocki-Lupski Syndrome)

TP

de novo

8

arr[hg19]Xp28(152,713,658-153,421,838) × 3

0.69

VSD; TR

P

TP

de novo

9

arr[hg19]3q24q25.1(143,476,996-151,222,561) × 1

7.7

VSD; ocular hypertelorism; widening of lateral ventricle

P

TP

de novo

10

arr[hg19]15q24.1q24.2(72,965,465-75,567,135) × 1

2.6

VSD; PA; FGR; Absence of nasal bone

P

TP

de novo

11

arr[hg19]3q29(195,743,957-197,386,180) × 3

1.6

VSD

P

TP

de novo

12

arr[hg19]7q11.23(72,701,098-74,069,645) × 3

1.3

VSD; Left kidney dysplasia

P

TP

de novo

13

arr[hg19]16q23.2q24.3(79,800,878-90,146,366)hmz,16p13.3p12.3(94,807-19,302,326)hmz

10.3

VSD; PVS; Left kidney dysplasia; FGR

P

TP

UPD

14

arr[hg19]11P15.1P14.3(20,745,930-21,780,075) × 3

1.0

VSD; Right hydronephrosis; widening of left lateral ventricle

VOUS

TP

De novo

15

arr[hg19]4q24(106,284,925-107,545,257) × 3

1.2

VSD; ARSA; FGR

VOUS

TD

De novo

16

arr[hg19]9q21.33q22.1(89,868,507-90,975,015) × 3

1.1

VSD

VOUS

TD

De novo

17

arr[hg19]16p13.11(14,897,401-16,534,031) × 1

0.5

VSD; Left ventricular hyperechoic

VOUS

TD

De novo

18

arr[hg19]2q31.2q31.3(180,558,684-181,901,189) × 3

0.5

VSD; OFB

VOUS

TD

De novo

19

arr[hg19]5q14.1(76,983,283-77,512,158) × 3

0.5

VSD

B

TD

Maternal

20

arr[hg19]10q21.1(59,095,330-60,684,488) × 1

1.5

VSD; TR

B

TD

Maternal

  1. ALSA aberrant left subclavian artery, ARA aortic ride across, ARSA aberrant right subclavian artery, B benign, CMA chromosomal microarray analysis, CNVs copy number variations, FGR fetal growth restriction, LSVC left superior vena cava, OFB oval flaps bulging, P Pathogenic, PA pulmonary atresia, PVS pulmonary valve stenosis, RAA right aortic arch, TR tricuspid regurgitation, TD term delivery, TP termination of pregnancy, UPD uniparental disomy, VOUS variation of uncertain clinical significance, VSD ventricular septal defect, VC vascular circle